Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triheptanoin for the treatment of glucose transport 1 deficiency

Triheptanoin for the treatment of glucose transport 1 deficiency

US Patent 9468229 · Granted Oct 18, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of gangliosides metabolism for the treatment of motor neuron diseases2021
Anaplerotic therapy of huntington disease and other polyglutamine diseases2019
Triheptanoin for the treatment of glucose transport 1 deficiency2018
Triheptanoin for the treatment of glucose transport 1 deficiency2018
Urinary triaosylceramide (Gb3) as a marker of cardiac disease2017
Urinary triaosylceramide (Gb3) as a marker of cardiac disease2017
Anaplerotic therapy of huntington disease and other polyglutamine diseases2017
Establishment of patient- or person-specific cardiac myocyte cell lines from hum2015
Urinary triaosylceramide (GB3) as a marker of cardiac disease2015
Urinary triaosylceramide (GB3) as a marker of cardiac disease2015
Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease2013